Deoxycytidine kinase (dCK) is one of the key enzymes of deoxynucleoside salvage supplying resting lymphocytes with DNA precursors for synthesis and repair. The level of dCK activity is especially important in chemotherapy with the use of deoxynucleoside analogues like arabinosyl cytosine (Citarabid, ara-C), or 2-chloro-deoxyadenosine (Cladribine, CdA). Previous results showed that Cladribine treatment of human lymphocytes increased several fold the activity of dCK without increasing the amount of dCK protein itself (Sasvári-Székely, et al., 1998, Biochem. Pharmacol. 56, 1175), and a possible post-translational modification was suggested. This theory was further investigated using NaF as an inhibitor of protein phosphatases. It was shown that NaF treatment of cells elevated dCK activity while inhibiting DNA synthesis. The possible mechanism of dCK activation/inactivation induced by exposure of cell cultures to different agents is discussed.
Lymphangiomatous polyps of the palatine tonsil are a rare clinical entity with only about 30 odd cases ever reported. All the cases in the literature were described as unilateral tonsillar diseases, except for one paediatric case which had bilateral tonsillar involvement. Due to its unilateral presentation and suspicious appearance similar to tonsillar malignancy, lymphangiomatous polyps may cause heightened anxiety to both patients and doctors alike on a routine oropharyngeal examination. Owing to its rarity and a variety of complex nomenclatures, this condition may also be confusing to the treating otolaryngologist as well as junior pathologist. We report an extremely rare case of bilateral tonsillar lymphangiomatous polyps in a snoring child that was successfully treated surgically via tonsillectomy.
PL
Polipy o charakterze naczyniaka chłonnego migdałka podniebiennego są w praktyce klinicznej odnotowywane bardzo rzadko – dotychczas opisano jedynie około 30 przypadków. Zazwyczaj stwierdzano jednostronne zmiany w obrębie migdałka podniebiennego, tylko u jednego dziecka migdałki były zajęte obustronnie. Polipy o charakterze naczyniaka chłonnego mogą budzić zaniepokojenie pacjenta oraz lekarza ze względu na umiejscowienie po jednej stronie oraz wygląd przypominający nowotwór migdałka. Zważywszy na rzadkość występowania oraz różnorodność nazewnictwa jednostka ta może być również trudna do rozpoznania zarówno dla otolaryngologa, jak i niedoświadczonego patologa. Przedstawiamy niezwykle rzadki przypadek obustronnych polipów migdałka o charakterze naczyniaka chłonnego u dziecka z problemem chrapania, u którego skuteczny okazał się zabieg tonsillektomii.
Objective: The aim of this study was to compare QoL of oropharyngeal cancer survivors who had received different treatments. Subjects and methods: We contacted 954 survivors. Each survivor received the QoL questionnaires EORTC QLQ-C30 and EORTC QLQ-H&N35. Results: A total of 263 survivors completed the questionnaires (28% responses). Forty-five of them had undergone surgery, 20 had received definitive radiotherapy or chemo-radiotherapy, 85 surgery plus adjuvant radiotherapy, and 111 surgery plus adjuvant chemo-radiotherapy. Survivors who had received adjuvant radiotherapy and surgery reported significantly more problems with swallowing (B=13.43 [95% Confidence Interval (CI) 1.83-25.03]), senses (B=24,91 [CI 11.86-37.97]), eating (B=16.91 [CI 3.46-30.36]), dry mouth (B=26.42 [CI 12.17-40.67]), sticky saliva (B=22.37 [CI 6.23-38.50]) and nutritional supplements (B=18.59 [CI 0.62-36.56]) than those who had received surgery only. Survivors who had received adjuvant chemo-radiotherapy and surgery reported significantly many more problems with dry mouth (B=34.15 [CI 18.91-49.39]) and sticky saliva (B=22.90 [CI 5.65-40.16]), and fewer problems with physical functioning (B=-12.07 [CI 0.49-23-64]). Conclusion: Survivors who participated in this survey and who had undergone surgery alone reported in some head- and neck-specific domains a better health-related quality of life than patients who had undergone multi-modal treatment or adjuvant radiotherapy.
Objective: The aim of this study was to compare QoL of oropharyngeal cancer survivors who had received different treatments. Subjects and methods: We contacted 954 survivors. Each survivor received the QoL questionnaires EORTC QLQ-C30 and EORTC QLQ-H&N35. Results: A total of 263 survivors completed the questionnaires (28% responses). Forty-five of them had undergone surgery, 20 had received definitive radiotherapy or chemo-radiotherapy, 85 surgery plus adjuvant radiotherapy, and 111 surgery plus adjuvant chemo-radiotherapy. Survivors who had received adjuvant radiotherapy and surgery reported significantly more problems with swallowing (B=13.43 [95% Confidence Interval (CI) 1.83-25.03]), senses (B=24,91 [CI 11.86-37.97]), eating (B=16.91 [CI 3.46-30.36]), dry mouth (B=26.42 [CI 12.17-40.67]), sticky saliva (B=22.37 [CI 6.23-38.50]) and nutritional supplements (B=18.59 [CI 0.62-36.56]) than those who had received surgery only. Survivors who had received adjuvant chemo-radiotherapy and surgery reported significantly many more problems with dry mouth (B=34.15 [CI 18.91-49.39]) and sticky saliva (B=22.90 [CI 5.65-40.16]), and fewer problems with physical functioning (B=-12.07 [CI 0.49-23-64]). Conclusion: Survivors who participated in this survey and who had undergone surgery alone reported in some head- and neck-specific domains a better health-related quality of life than patients who had undergone multi-modal treatment or adjuvant radiotherapy.
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.